Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2025 18:00 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
December 15, 2025 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
November 20, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling
November 14, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth
November 13, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data
November 13, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
October 01, 2025 08:00 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
August 12, 2025 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
November 16, 2024 06:57 ET | Source: OnePiece Labs

AEON Web3 University Tour Culminates with Final Stop at SFU

PALO ALTO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- The Web3 University Tour series, hosted by AEON and OnePiece Labs in Q4 2024, is a groundbreaking initiative connecting students with the...
March 25, 2021 09:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™

Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...